Vaccinex Inc (NASDAQ:VCNX) Stock Suddenly Gains Momentum: Jumps 9%

January 27, 2022

Clinical stage biotech firm Vaccinex Inc (NASDAQ:VCNX) could be one to watch this morning considering the fact that the company’s stock had emerged as one of the major gainers yesterday. Investors piled on to the Vaccinex stock in a big way yesterday and sent it soaring by as much as 9%. Trading Data On Tuesday, VCNX stock gained 8.82% to $1.1 with more than 42.27 million shares, compared to its…